Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pulmonary Disease, Chronic Obstructive × CIMAvax EGF × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pulmonary Disease, Chronic Obstructive 1 Pneumonia 1 Lung Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

perflutren 1 Sulfur Hexafluoride 1 CIMAvax EGF 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04298606 2026-03-17

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonia, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡